CLEARNANO INC
Plano, TX · Medtech · Private
ClearICG, a near-infrared fluorescent imaging agent for intraoperative visualization of kidney cancer tumors during partial nephrectomy
- Grants
- $5.2M
- 9 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720182019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Renal clearable NIR-emitting gold nanoparticles for early detection of drug-induced nephrotoxicity | $224,593 | |
| Federal grant | Department of Health and Human Services · Phase I · Renal clearable NIR-emitting gold nanoparticles for early detection of drug-induced nephrotoxicity | $30,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Advance Early Detection of Lupus Nephritis with ClearGold | $288,365 | |
| Federal grant | Department of Health and Human Services · Phase II · Advancing Fluorescence Imaging-guided Partial Nephrectomy with ClearICG | $385,318 | |
| Federal grant | Department of Health and Human Services · Phase II · STTR Phase II: Advance Early Detection of Lupus Nephritis with ClearGold | $809,923 | |
| Federal grant | Department of Health and Human Services · Phase II · STTR Phase II: Advance Early Detection of Lupus Nephritis with ClearGold | $605,187 | |
| Federal grant | Department of Health and Human Services · Phase II · Advancing Fluorescence Imaging-guided Partial Nephrectomy with ClearICG | $851,516 | |
| Federal grant | Department of Health and Human Services · Phase II · Advancing Fluorescence Imaging-guided Partial Nephrectomy with ClearICG | $851,516 | |
| Federal grant | Department of Health and Human Services · Phase II · Advancing Fluorescence Imaging-guided Partial Nephrectomy with ClearICG | $1,126,552 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1798 | PRECISION MEMBRANES, LLC | — | — |
| 1799 | LED RADIOFLUIDICS CORP | — | — |
| 1800 | EPIPHANY BIOSCIENCES, INC. | — | — |
| 1801 | CLEARNANO INC | — | — |
| 1802 | MABDX, INC. | — | — |
| 1803 | HEARTVISTA, INC. | — | — |
| 1804 | TF HEALTH CORPORATION | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.